Vivital Biomed Ltd.

 

Vvital is dedicated to improving the long-term stability of Transcatheter Mitral Valve Repair (TMVRr).

Based on the invention of Prof. Aram Smolinsky, Vvital developed the VLR system providing Valve Leaflet Repair with an Annuloplasty effect in one procedure.  

 

This unique combination, up to now present only in surgical procedures, is a true game changer in  Transcatheter MR treatment. 

Trendlines logo.png

Investor

The Trendlines Group

Management

Nir Golan

CEO, Co-founder

Mr. Nir Golan has 25 years’ experience in executive business management in leading global public high-tech companies and start-ups; extensive experience in business development, M&A, start-up establishment, technology, global sales, and marketing; B.A., economics, Tel Aviv University; Executive MBA, The Hebrew University of Jerusalem.

  • LinkedIn

Prof. Aram Smolinsky, M.D. 

CMO, Co-founder & Inventor 

Prof. Aram Smolinsky has 35  years’ clinical and academic experience as cardiac surgeon and researcher; former director of Open-Heart Surgery Department, Sheba Medical Center; performed >7,000 open-heart procedures; leader in mitral valve repair operations in Israel; M.D. and Associate Professor of Surgery, Sackler School of Medicine, Tel Aviv University.

  • LinkedIn

Yaniv Marmur

VP R&D

Mr. Yaniv Marmur has 10 years’ engineering and R&D experience in the medical device industry. Strong background in design and development of transcatheter delivery systems and implants; with expertise in planning, developing and leading teams in technological development projects and clinical trials. Yaniv holds a B.Sc in mechanical engineering from the Technion-Israel Institute of Technology.

  • LinkedIn

Vvital Biomed Restores Native Vitality

  • LinkedIn
  • YouTube